Back to
Nuveen Asset Management, LLC
RNAC
Showing 1 of 3 quarters
Position history for
Nuveen Asset Management, LLC's holdings in Cartesian Therapeutics, Inc.
As of its last 13F, for Q4 2024, Nuveen Asset Management held 72,099 shares of RNAC (Cartesian Therapeutics), worth $1.3M. It increased the position by 47,889 shares (+197.8%) from Q3 2024. Nuveen Asset Management listed RNAC in each of its last 3 quarterly 13F filings.
Current Value
$1.3M
Current Shares
72,099
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC